July 14, 2022
The Medical University of South Carolina (MUSC) Zucker Institute for Applied Neuroscience (ZIAN) and MUSC Foundation for Research Development (FRD) have announced they will be joining forces and will begin collectively doing business as the “Zucker Institute for Innovation Commercialization” effective immediately.
SCBIO CEO James Chappell has been named to the organization’s newly formed Board of Directors.
The new combined institute solidifies MUSC’s commercialization efforts into a single more powerful engine with an increased ability to execute on its mission of facilitating the creation of new products and services that improve lives.
Read full article, HERE.